Skip to content

A prospective, non-randomized, controlled study comparing the effect of an medial pivot design with a PS design on mid-flexion stability of the knee

A prospective, non-randomized, controlled study comparing the effect of an medial pivot design with a PS design on mid-flexion stability of the knee

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082933
Enrollment
Unknown
Registered
2024-04-11
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the Knee Joint.

Interventions

PS design group:The patient will be operated with a PS design implant
medial pivot design group:The patient will be operated with a medial pivot design implant

Sponsors

Senior Department of Orthopedics, Fourth Medical Center of People’s Liberation Army General Hospital, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients under 80 years of age with osteoarthritis of the knee joints, proposed to undergo unilateral robot-assisted total knee arthroplasty, who are capable of autonomous behavior, willing to follow study instructions and complete all required follow-up visits and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Patients with valgus knee, severe flexion contracture deformity (flexion contracture >15°), severe varus knee (>15°); combined hematologic related disorders; and patients taking medications affecting the coagulation system within 1 month prior to surgery will be excluded from the trial.

Design outcomes

Primary

MeasureTime frame
Anteroposterior stability of the knee;

Secondary

MeasureTime frame
HKA angle;LDFA;MPTA;PPTA;KSS score;WOMAC score;VAS score;

Countries

China

Contacts

Public ContactWei Chai

Senior Department of Orthopedics, Fourth Medical Center of People’s Liberation Army General Hospital, Beijing, China

chaiwei301@163.com+86 10 6684 8810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026